Brookdale Senior Living (BKD)
(Delayed Data from NYSE)
$6.10 USD
+0.10 (1.67%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $6.11 +0.01 (0.16%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Brookdale Senior Living (BKD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.75 | $9.00 | $6.50 | 29.17% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Brookdale Senior Living comes to $7.75. The forecasts range from a low of $6.50 to a high of $9.00. The average price target represents an increase of 29.17% from the last closing price of $6.00.
Analyst Price Targets (2 )
Broker Rating
Brookdale Senior Living currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 2.50 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, one is Buy, representing 50% of all recommendations. A month ago, Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
Not Identified | Not Identified | Not Identified | Not Identified | Not Identified |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 2 |
Average Target Price | $7.75 |
LT Growth Rate | 20.90% |
Industry | Medical - Nursing Homes |
Industry Rank by ABR | 217 of 252 |
Current Quarter EPS Est: | -0.17 |